| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.56.7.890 |
| P698 | PubMed publication ID | 11294926 |
| P50 | author | Munir Pirmohamed | Q20127995 |
| P2093 | author name string | K Lin | |
| B K Park | |||
| D Chadwick | |||
| P2860 | cites work | Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium | Q22122334 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 890-896 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients | |
| P478 | volume | 56 |
| Q57302751 | Adverse drug reactions and pharmacogenomics: recent advances |
| Q35130832 | Adverse drug reactions: back to the future |
| Q46667920 | Association between TNFA-308 G/A polymorphism and sensitization to para-phenylenediamine: a case-control study |
| Q34117815 | Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir |
| Q44796890 | Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations |
| Q80243406 | Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population |
| Q34435476 | Carbamazepine-induced acute liver failure as part of the DRESS syndrome. |
| Q42132518 | Cutaneous drug hypersensitivity: immunological and genetic perspective |
| Q34810493 | Cytokine gene polymorphism in human disease: on-line databases, supplement 2. |
| Q57302790 | Drug metabolism and drug toxicity |
| Q27030788 | Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts |
| Q27692095 | Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. |
| Q37765824 | Gene polymorphisms and their role in epilepsy treatment and prognosis |
| Q36555922 | Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications |
| Q34508545 | Genetic factors in the predisposition to drug-induced hypersensitivity reactions |
| Q34275394 | Genetic susceptibility to adverse drug reactions |
| Q41704639 | HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients. |
| Q34172669 | HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans |
| Q34566776 | HLA-B locus in Caucasian patients with carbamazepine hypersensitivity |
| Q30238992 | Human leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity. |
| Q92436059 | Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond |
| Q36770454 | Idiosyncratic adverse reactions to antiepileptic drugs |
| Q35051172 | Immunopharmacology of hypersensitivity reactions to drugs |
| Q51753343 | Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele. |
| Q36439171 | Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions |
| Q42008292 | Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report |
| Q34605798 | Oxcarbazepine-induced Stevens-Johnson syndrome: a case report |
| Q57223243 | Personalized medicine for HLA-associated drug-hypersensitivity reactions |
| Q42157342 | PharmGKB summary: carbamazepine pathway |
| Q57302676 | Pharmacogenetics of Adverse Drug Reactions |
| Q35873680 | Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity |
| Q34118186 | Pharmacogenetics of drug hypersensitivity |
| Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
| Q57302677 | Response 2 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: a critical appraisal |
| Q61479942 | Systemic Reactions to HHV-6 Infection |
| Q45958696 | TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole. |
| Q53395242 | TNF-α genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. |
| Q37216732 | The clinical impact of pharmacogenetics on the treatment of epilepsy |
| Q34574033 | The pharmacogenomics of HIV therapy. |
| Q36545002 | Theragenomic knowledge management for individualised safety of drugs, chemicals, pollutants and dietary ingredients |
| Q36373816 | Update on pharmacogenetics in epilepsy: a brief review. |
| Q36729620 | Various pharmacogenetic aspects of antiepileptic drug therapy: a review |
Search more.